---  
layout: startup_page  
title: "Alentis Therapeutics"  
id: "alentis.ch"  
permalink: "/alentistherapeuticsalentis.ch11122024/"  
website: "https://alentis.ch/"  
funding_round: "Series D"  
funding_amount: "$181.4M"  
investors: "OrbiMed, Novo Holdings, Jeito Capital, Frazier Life Sciences, Longitude Capital, RA Capital, Catalio Capital, Piper Heartland Healthcare Capital, Avego Bioscience Capital, Morningside Venture Investments, BB Pureos, Bpifrance"  
about: "Alentis Therapeutics is a clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis. They focus on creating first-in-class antibody-drug conjugates (ADCs) targeting CLDN1, a previously unexploited target in cancer treatment. Their approach aims to provide highly effective cancer treatments with less toxicity than traditional methods."  
markets: "Biotechnology, Oncology"  
hq: "Allschwil, Basel-Country, Switzerland"  
founded_year: "2019"  
linkedin: "https://www.linkedin.com/company/alentis-therapeutics"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/alentis-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/267157-99"  

date_display: "12-Nov-2024"  
date: "2024-11-12"

# SEO Optimization  
meta_title: "Alentis Therapeutics - Series D Funding ($181.4M)"  
meta_description: "Alentis Therapeutics, Alentis Therapeutics is a clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis. They f..."  
meta_keywords: "Alentis Therapeutics, Biotechnology, Oncology, Series D funding"  
canonical_url: "https://startup.projectstartups.com/alentistherapeuticsalentis.ch11122024/"  
---